Literature DB >> 24610065

Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey.

Chantal Csajka1, Aurélie Jaquet, Ursula Winterfeld, Yvonne Meyer, Adrienne Einarson, Alice Panchaud.   

Abstract

PRINCIPLE: Healthcare professionals' (HCPs') perception of risk associated with drug use in pregnancy may have an impact on the pharmacological treatment of some women. The aim of this study was to examine this risk perception in a sample of Swiss HCPs with a special focus on their knowledge and use of available specialised information sources.
METHOD: An online, French and German, questionnaire was e-mailed to 7,136 members of four Swiss professional societies (gynaecologists, paediatricians, midwives and pharmacists). The questionnaire was designed (a) to collect demographic characteristics, (b) to evaluate the frequency of use of several specialised sources of information on drugs in pregnancy in their daily practice, and (c) to examine the perception of risk associated with drug use during pregnancy.
RESULTS: A total of 1,310 questionnaires were collected (response rate of 18.4%). More than 80% of the respondent HCPs use the Swiss Drug Reference Book (Compendium) to assess the risk associated with drugs during pregnancy and are not aware of available specialised information sources (books, websites or information centres). Despite some disparities between HPCs, the risk related to drug intake was overall highly misperceived. Blinded reading of three product monographs in the Compendium was associated with an overestimated perception of risk (e.g., after reading the "paracetamol" monograph, 38% of the participants stated they would probably not advise the use of this drug to a pregnant patient).
CONCLUSION: Overall, an overestimation of the risk associated with drug use during pregnancy has been observed in our sample of HCPs, which might be related to the underuse of specialised information source among other factors. These findings evidenced the need for increased training for HCPs in order to optimise medication use during pregnancy. Further studies are needed to confirm these results and identify causes.

Entities:  

Mesh:

Year:  2014        PMID: 24610065     DOI: 10.4414/smw.2014.13936

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  8 in total

1.  Knowledge Valuation by Iranian Women with High-Risk Pregnancy: A Qualitative Content Analysis.

Authors:  Zahra Shojaeian; Talat Khadivzadeh; Ali Sahebi; Hossein Kareshki; Fatemeh Tara
Journal:  Int J Community Based Nurs Midwifery       Date:  2020-07

2.  Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.

Authors:  Charlotte Gils; Anton Pottegård; Zandra Nymand Ennis; Per Damkier
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-17       Impact factor: 3.007

3.  Risks versus benefits of medication use during pregnancy: what do women perceive?

Authors:  Bianca Mulder; Maarten J Bijlsma; Catharina Cm Schuiling-Veninga; Leonard P Morssink; Eugene van Puijenbroek; Jan G Aarnoudse; Eelko Hak; Tjalling W de Vries
Journal:  Patient Prefer Adherence       Date:  2017-12-20       Impact factor: 2.711

4.  Perception of Environmental Risks and Health Promotion Attitudes of French Perinatal Health Professionals.

Authors:  Cécile Marie; Didier Lémery; Françoise Vendittelli; Marie-Pierre Sauvant-Rochat
Journal:  Int J Environ Res Public Health       Date:  2016-12-18       Impact factor: 3.390

5.  Risk perception, beliefs about medicines and medical adherence among pregnant and breastfeeding women with migraine: findings from a cross-sectional study in Norway.

Authors:  Siri Amundsen; Torunn Gudmestad Øvrebø; Netta Marie Skretteberg Amble; Anne Christine Poole; Hedvig Nordeng
Journal:  BMJ Open       Date:  2019-02-27       Impact factor: 2.692

6.  Perceived Risk in Women with High Risk Pregnancy: A Qualitative Study.

Authors:  Zahra Shojaeian; Talat Khadivzadeh; Ali Sahebi; Hossein Kareshki; Fatemeh Tara
Journal:  Iran J Nurs Midwifery Res       Date:  2021-03-05

7.  Medications and pregnancy: The role of community pharmacists - A descriptive study.

Authors:  Hoi Ying Leung; Bandana Saini; Helen E Ritchie
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

8.  Prescribing antidepressants and anxiolytic medications to pregnant women: comparing perception of risk of foetal teratogenicity between Australian Obstetricians and Gynaecologists, Speciality Trainees and upskilled General Practitioners.

Authors:  Summer Williams; George Bruxner; Emma Ballard; Alka Kothari
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-14       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.